175 related articles for article (PubMed ID: 15313161)
1. A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotype.
Ishiguro A; Kubota T; Sasaki H; Iga T
Clin Chim Acta; 2004 Sep; 347(1-2):217-21. PubMed ID: 15313161
[TBL] [Abstract][Full Text] [Related]
2. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.
Broly F; Meyer UA
Pharmacogenetics; 1993 Jun; 3(3):123-30. PubMed ID: 8101460
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
[TBL] [Abstract][Full Text] [Related]
4. Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.
Bathum L; Johansson I; Ingelman-Sundberg M; Hørder M; Brøsen K
Pharmacogenetics; 1998 Apr; 8(2):119-23. PubMed ID: 10022749
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of CYP2D6 in the Japanese population.
Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
[TBL] [Abstract][Full Text] [Related]
6. CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.
Kato D; Kawanishi C; Kishida I; Furuno T; Matsumura T; Hasegawa H; Suzuki K; Hirayasu Y
Psychiatry Clin Neurosci; 2005 Aug; 59(4):504-7. PubMed ID: 16048458
[TBL] [Abstract][Full Text] [Related]
7. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
[TBL] [Abstract][Full Text] [Related]
8. Determination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis.
Leandro-García LJ; Leskelä S; Montero-Conde C; Landa I; López-Jimenez E; Letón R; Seeringer A; Kirchheiner J; Cascón A; Robledo M; Rodríguez-Antona C
Anal Biochem; 2009 Jun; 389(1):74-6. PubMed ID: 19303860
[TBL] [Abstract][Full Text] [Related]
9. Novel structure of the CYP2D6 gene that confuses genotyping for the CYP2D6*5 allele.
Fukuda T; Maune H; Ikenaga Y; Naohara M; Fukuda K; Azuma J
Drug Metab Pharmacokinet; 2005 Oct; 20(5):345-50. PubMed ID: 16272752
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cytochrome P450 2D6 alleles using the Invader system.
Nevilie M; Selzer R; Aizenstein B; Maguire M; Hogan K; Walton R; Welsh K; Neri B; de Arruda M
Biotechniques; 2002 Jun; Suppl():34-8, 40-3. PubMed ID: 12083395
[TBL] [Abstract][Full Text] [Related]
11. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Arneth B; Shams M; Hiemke C; Härtter S
Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of CYP2D6 in Chinese mainland.
Ji L; Pan S; Wu J; Marti-Jaun J; Hersberger M
Chin Med J (Engl); 2002 Dec; 115(12):1780-4. PubMed ID: 12622923
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 and CYP1A1 mutations in the Turkish population.
Aydin M; Hatirnaz O; Erensoy N; Ozbek U
Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
[TBL] [Abstract][Full Text] [Related]
14. Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
Evans WE; Relling MV
Mol Pharmacol; 1990 May; 37(5):639-42. PubMed ID: 1971090
[TBL] [Abstract][Full Text] [Related]
15. Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population.
Mitsunaga Y; Kubota T; Ishiguro A; Yamada Y; Sasaki H; Chiba K; Iga T
Mutat Res; 2002 Aug; 505(1-2):83-5. PubMed ID: 12175908
[TBL] [Abstract][Full Text] [Related]
16. Rapid assignment of the swine major histocompatibility complex (SLA) class I and II genotypes in Clawn miniature swine using PCR-SSP and PCR-RFLP methods.
Ando A; Ota M; Sada M; Katsuyama Y; Goto R; Shigenari A; Kawata H; Anzai T; Iwanaga T; Miyoshi Y; Fujimura N; Inoko H
Xenotransplantation; 2005 Mar; 12(2):121-6. PubMed ID: 15693842
[TBL] [Abstract][Full Text] [Related]
17. No evidence of an association between CYP2D6 polymorphisms among Japanese and dementia with Lewy bodies.
Furuno T; Kawanishi C; Iseki E; Onishi H; Sugiyama N; Suzuki K; Kosaka K
Psychiatry Clin Neurosci; 2001 Apr; 55(2):89-92. PubMed ID: 11285084
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
19. A novel diagnostic test detects a low frequency of the hemicentin Gln5345Arg variant among Northern Irish age related macular degeneration patients.
McKay GJ; Clarke S; Hughes A; McConnell V; Schultz DW; Klein ML; Silvestri G; Simpson DA
Mol Vis; 2004 Sep; 10():682-7. PubMed ID: 15467524
[TBL] [Abstract][Full Text] [Related]
20. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
